Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine for pain management in patients undergoing TEVAR for descending aortic dissection or thoracoabdominal aortic aneurysm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Sam Tyagi | Conditions: Descending Aortic Dissection, Postoperative Pain | Phase 2 | Status: RECRUITING